Rigorous clinical validation, transparent algorithmic reasoning.
Built in collaboration with leading longevity physicians, epidemiologists, and computational biologists. Every correlation is cited, quantified, and benchmarked against peer-reviewed clinical trials.
Featured Multi-Omic Cohort Study
Longitudinal Multi-Omic Biometric Profiling in Early Detection of Subclinical Metabolic Drift
Evaluating the efficacy of continuous autonomous biomarker inference engines in flagging impaired fasting glucose, microvascular arterial stiffness, and occult systemic inflammation up to 28 months prior to primary standard-of-care diagnosis.
Continuous CGM + high-density quarterly metabolomics assay
n=2,400 (ages 28–74, balanced distribution across 3 academic medical centers)
Detection of pre-diabetic drift before HbA1c elevation (>5.7%)
Meridian algorithmic stratification isolated early metabolic divergence with a hazard ratio (HR) of 3.42 (95% CI 2.88–4.06, p < 0.0001) relative to conventional annual wellness panels, conferring an average therapeutic intervention runway of 840 days.
Deterministic clinical engines, not generative speculation.
Meridian enforces a strict mathematical guarantee: no generative LLM ever formulates diagnostic output. Recommendations are governed by supervised Bayesian belief networks and verified clinical pathways mapped directly to NIH, ACC/AHA, and Endocrine Society thresholds.
Raw Multi-Signal Telemetry
Concurrent identification of diverging physiological vectors:
Confounding Factor Pruning
Algorithmic exclusion of benign transient causes via behavioral sync:
- check Acute infection/rhinovirus: Excluded
- check Overtraining syndrome: Excluded
- check Ethanol perturbation: Excluded
Bayesian Network Evaluation
Calculates likelihood against longitudinal multi-center historical registry:
Peer-Reviewed Protocol Output
Generates cited physician directive without speculative language:
Target ApoB titration < 60 mg/dL + nocturnal recovery modification.
Ref: Ridker PM et al., NEJM 2017; JAMA Cardiol 2023.Guided by premier clinical investigators.
Our methodology is audited quarterly by practicing clinicians and bioinformaticians from the world's foremost medical research centers.
Dr. Aris Thorne, MD, PhD
Chief Medical Officer Former Harvard Medical School FellowSpecialist in molecular hallmarks of cellular senescence and continuous biomarker stratification. Over 40 published studies in cellular longevity.
Dr. Elena Rostova, MD
Cardiovascular Biomarkers Stanford Medicine Preventive CardiologyPioneer in non-invasive microvascular monitoring and longitudinal lipid subfraction tracking for early coronary arterial calcification arrest.
Marcus Vance, PhD
Computational Biology MIT Health Sciences & TechnologyArchitect of multi-omic Bayesian networks and deterministic causal inference engines. Specializes in statistical modeling of subclinical physiological anomalies.
Dr. Priya K., MD
Early Biomarker Detection Dana-Farber Cancer InstituteClinical researcher evaluating circulating cell-free methylated DNA markers and systemic inflammatory baselines in early somatic transformation.
Research Ethics & Governance Charter
Biomarker intelligence demands uncompromising governance. Meridian guarantees patient-sovereign control through mathematically verifiable protocols.
No Black-Box AI Models
Every inference score is traceable to explicit mathematical coefficients. Clinicians can inspect each Bayesian conditional node directly in the Meridian audit console.
Physician-in-the-Loop Safeguards
High-variance biomarker anomalies trigger mandatory asynchronous physician reviews before patient-facing notifications are delivered, preventing panic.
Zero-Knowledge Cryptography
Biometric telemetry is encrypted client-side using zk-SNARK protocols. Algorithms execute on obfuscated payloads; personal identities remain segregated at all times.
Open Academic Sharing
De-identified population-level drift statistics are made available freely to accredited universities and researchers via our public Academic API endpoint.
Review the science behind predictive longevity.
Access our comprehensive 120-page clinical dossier, full methodology datasets, and peer-reviewed ROC calibration curves.